⌘K

Login Start Free

Home/Filings/4/0001062993-23-005024

4//SEC Filing

Smeykal Megan 4

Accession 0001062993-23-005024

CIK 0001561921other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 7:14 PM ET

Size

5.9 KB

Accession

0001062993-23-005024

Insider Transaction Report

Form 4

Period: 2023-02-23

TELA Bio, Inc.TELA

Chief Accounting OfficerOther

Transactions

Tax Payment
Common Stock
2023-02-24$11.03/sh−539$5,945→ 20,527 total
Tax Payment
Common Stock
2023-02-23$10.50/sh−423$4,442→ 21,066 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1

filerCIK 0001899973

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 7:14 PM ET
Size: 5.9 KB

View on SEC.gov